title: Optimization, characterisation and pharmacokinetic studies of mucoadhesive oral multiple unit systems of ornidazole.
abstract: The objective of the present study was to investigate the applicability of matrix type mucoadhesive oral multiple unit systems (MUS) for sustaining the release of ornidazole in the gastrointestinal tract (GIT). The MUS were prepared by ionotropic gelation method using chitosan and hydroxypropyl methyl cellulose K4M (HPMC K4M) according to 3(2) factorial designs and were evaluated in vitro and in vivo. The particle size length ranged from 0.78 to 1.30 mm and breadth from 0.76 to 1.30 mm, respectively. The entrapment efficiency was in range of 80 to 96%. The rapid wash-off test was observed faster at intestinal pH 6.8 as compared to acidic pH 1.2. The fluoroscopic study revealed the retention of MUS in GIT for more than 5 hours. The pharmacokinetic parameters C(max), T(max), mean residence time (MRT) and area under curve (AUC) of developed MUS were found to be improved significantly (p<0.05) when compared with marketed immediate release tablets each containing 500 mg of drug. This study demonstrates that the MUS could be a good alternative to immediate release tablets to deliver ornidazole and expected to be less irritant to gastric and intestinal mucosa.
authors: Department of Pharmaceutics, Pravara Rural College of Pharmacy, Loni- 413736, India. asanegovind@gmail.com
authors: Govind S
authors: GS
authors: Asane
authors: Yamsani Madhusudan
authors: YM
authors: Rao
authors: Jaykrishna H
authors: JH
authors: Bhatt
authors: Karimunnisa S
authors: KS
authors: Shaikh
references: Eur J Pharm Sci. 2001 May;13(2):123-33
references: 11297896
references: Curr Drug Deliv. 2007 Jan;4(1):41-50
references: 17269916
references: Drug Deliv. 2000 Oct-Dec;7(4):237-43
references: 11195431
references: Clin Pharmacokinet. 1999 May;36(5):353-73
references: 10384859
references: Drug Dev Ind Pharm. 2009 Oct;35(10):1155-66
references: 19555239
references: Int J Pharm. 2003 Apr 30;256(1-2):43-52
references: 12695010
references: J Drug Target. 2003 Feb;11(2):109-15
references: 12881197
references: Adv Drug Deliv Rev. 1998 May 4;31(3):267-285
references: 10837629
references: Int J Pharm. 2006 Apr 7;312(1-2):166-73
references: 16497452
references: Drug Dev Ind Pharm. 2003 Jul;29(6):713-24
references: 12889789
references: Pharm Res. 1990 Mar;7(3):264-9
references: 2339100
references: J Clin Microbiol. 2000 Feb;38(2):763-7
references: 10655382
references: Int J Pharm. 2003 Apr 14;255(1-2):13-32
references: 12672598
references: Chem Pharm Bull (Tokyo). 1990 Oct;38(10):2871-3
references: 2076575
references: Crit Rev Ther Drug Carrier Syst. 2008;25(3):207-58
references: 18540839
references: Drug Dev Ind Pharm. 2009 May;35(5):548-54
references: 18946794
references: Methods Find Exp Clin Pharmacol. 1986 Oct;8(10):633-40
references: 3784702
references: Gut. 1986 Aug;27(8):886-92
references: 3732895